New Data from Two Clinical Studies Indicate High-Risk and Recurrent Prostate Cancers Can be Effectively Treated in 5 Days Using the Accuray CyberKnife® System

/PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that new data presented at the 2024 Radiosurgery Society Meeting in Chicago, Illinois...

Related Keywords

Washington ,United States ,Wisconsin ,Illinois ,Georgetown University ,District Of Columbia ,Chicago ,Beth Kaplan ,Seth Blacksburg ,Hadler Jr ,Vaibhav Sharma ,Zachary Wilson ,Georgetown University Hospital ,Facebook ,Linkedin ,Exchange Commission ,Youtube ,Technology In Cancer Research Treatment ,Radiosurgery Society Meeting ,Accuray Incorporated ,Data Also Underscores Potential Benefits ,Cyberknife System Sub Millimeter Accuracy ,Preserving Quality ,Society Meeting ,Chief Medical Officer ,Cyberknife System ,Knife Platform ,Prostate Cancer ,Private Securities Litigation Reform Act ,Quarterly Report ,Related Quality ,High Risk Prostate Cancer ,President Physician ,Toxicity Following ,Directed Focal Salvage Robotic ,Medical Student ,Robotic Radiosurgery System ,Cancer Research ,Relations Director ,